E-LIB Suche - Ergebnisse für: Deininger, Michael

1

Dose modification dynamics of ponatinib in patients with ch..:

Jabbour, Elias ; Apperley, Jane ; Cortes, Jorge...
Leukemia. 38 (2024) 3 - p. 475-481 , 2024

Link: https://doi.org/10.1038/..

2

Asciminib monotherapy in patients with chronic-phase chroni..:

Cortes, Jorge E. ; Sasaki, Koji ; Kim, Dong-Wook...
Leukemia. 38 (2024) 7 - p. 1522-1533 , 2024

Link: https://doi.org/10.1038/..

3

Globally coherent water cycle response to temperature chang..:

Konecky, Bronwen L. ; McKay, Nicholas P. ; Falster, Georgina M....
Nature Geoscience. , 2023

Link: https://doi.org/10.1038/..

4

European LeukemiaNet laboratory recommendations for the dia..:

Cross, Nicholas C. P. ; Ernst, Thomas ; Branford, Susan...
Leukemia. 37 (2023) 11 - p. 2150-2167 , 2023

Link: https://doi.org/10.1038/..

5

POSTER: CML-310 Early Cytogenetic or Molecular Landmark Res..:

Müller, Martin C. ; Cortes, Jorge ; Chuah, Charles...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S175 , 2023

Link: https://doi.org/10.1016/..

6

Molecular response in newly diagnosed chronic-phase chronic..:

Radich, Jerald P. ; Wall, Matthew ; Branford, Susan...
Haematologica. 108 (2023) 6 - p. 1567-1578 , 2023

Link: https://doi.org/10.3324/..

7

CML-313 Post Hoc Analysis of Patient Responses by T315I Mut..:

Cortes, Jorge ; Deininger, Michael ; Lomaia, Elza...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S338 , 2023

Link: https://doi.org/10.1016/..

8

AML-302 Targeting Small GTPase ARF6 Suppresses AML and Spar..:

Zhao, Helong ; Johnson, Kent ; Pomicter, Anthony...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S287-S288 , 2023

Link: https://doi.org/10.1016/..

9

POSTER: CML-313 Post Hoc Analysis of Patient Responses by T..:

Cortes, Jorge ; Deininger, Michael ; Lomaia, Elza...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S176 , 2023

Link: https://doi.org/10.1016/..

10

Pevonedistat with azacitidine in older patients with TP53-m..:

Saliba, Antoine N. ; Kaufmann, Scott H. ; Stein, Eytan M....
Blood Advances. 7 (2023) 11 - p. 2360-2363 , 2023

Link: https://doi.org/10.1182/..

11

POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is P..:

Apperley, Jane ; Cortes, Jorge ; Jabbour, Elias...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S179 , 2023

Link: https://doi.org/10.1016/..

12

POSTER: AML-302 Targeting Small GTPase ARF6 Suppresses AML ..:

Zhao, Helong ; Johnson, Kent ; Pomicter, Anthony...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S159 , 2023

Link: https://doi.org/10.1016/..

13

CML-305 Discovery of a Selective PROTAC Degrading Untamable..:

Rouhimoghadam, Milad ; Tang, Hua ; Bates, Briana...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S336 , 2023

Link: https://doi.org/10.1016/..

14

P662: POST HOC ANALYSIS OF PATIENT RESPONSES BY T315I MUTAT..:

Cortes, Jorge ; Deininger, Michael ; Lomaia, Elza...
HemaSphere. 7 (2023) S3 - p. e85501cf , 2023

Link: https://doi.org/10.1097/..

15

CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictiv..:

Apperley, Jane ; Cortes, Jorge ; Jabbour, Elias...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S339 , 2023

Link: https://doi.org/10.1016/..